Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements

[1]  T. Barbui,et al.  Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cells , 1998, British journal of haematology.

[2]  A. Zander,et al.  Highly‐efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin , 1998, British journal of haematology.

[3]  David A. Williams,et al.  High-Efficiency Gene Transfer into Normal and Adenosine Deaminase-Deficient T Lymphocytes Is Mediated by Transduction on Recombinant Fibronectin Fragments , 1998, Journal of Virology.

[4]  A. Zander,et al.  Impact of a new generation of gene transfer markers on gene therapy , 1998, Gene Therapy.

[5]  A. Zander,et al.  High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes. , 1998, Advances in experimental medicine and biology.

[6]  S. Hegewisch-Becker,et al.  Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. , 1998, Human gene therapy.

[7]  A. Zander,et al.  Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene. , 1997, Human gene therapy.

[8]  C. Bordignon,et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.

[9]  R. Morgan,et al.  Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. , 1997, Blood.

[10]  T. Kipps,et al.  Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Morgan,et al.  Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. , 1996, Human gene therapy.

[12]  David A. Williams,et al.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells , 1996, Nature Medicine.

[13]  E. Böhnlein,et al.  Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. , 1995, Gene therapy.

[14]  S. Rosenberg,et al.  T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.

[15]  R. Morgan,et al.  High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Krance,et al.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.

[17]  Daniel G. Miller,et al.  Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Garcia,et al.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.

[19]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.